Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3159)
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
300
Price
$82.53
Total Value
$24.76K
Shares Held After
54,324
% of Holdings
0.5%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
3,296
Price
$10.78
Total Value
$35.53K
Shares Held After
318,326
% of Holdings
1.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
21,649
Price
$10.77
Total Value
$233.16K
Shares Held After
2,525,429
% of Holdings
0.8%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
3,035
Price
$10.77
Total Value
$32.69K
Shares Held After
264,378
% of Holdings
1.1%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,897
Price
$10.78
Total Value
$20.45K
Shares Held After
326,898
% of Holdings
0.6%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
10
Price
$4.50
Total Value
$45.00
Shares Held After
2,433,270
% of Holdings
0.0%
Adlai Nortye Group Ltd. (ANL)
Ye Xiaofeng — CFO
Shares
6,000
Price
$13.98
Total Value
$83.88K
Shares Held After
153,424
% of Holdings
3.8%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
1,794
Price
$1.33
Total Value
$2.39K
Shares Held After
601,911
% of Holdings
0.3%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
906
Price
$19.10
Total Value
$17.30K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,305
Price
$513.35
Total Value
$669.92K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,592
Price
$512.46
Total Value
$1.84M
Shares Held After
325,748
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,056
Price
$511.63
Total Value
$1.56M
Shares Held After
329,340
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,323
Price
$510.52
Total Value
$675.42K
Shares Held After
332,396
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
224
Price
$509.41
Total Value
$114.11K
Shares Held After
333,719
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
330
Price
$6.98
Total Value
$2.30K
Shares Held After
51,851
% of Holdings
0.6%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
125,000
Price
$26.91
Total Value
$3.36M
Shares Held After
69,302
% of Holdings
64.3%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
107,374
Price
$1.75
Total Value
$188.36K
Shares Held After
4,853,818
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
53,613
Price
$10.64
Total Value
$570.44K
Shares Held After
1,373,397
% of Holdings
3.9%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
25,000
Price
$65.07
Total Value
$1.63M
Shares Held After
37,025
% of Holdings
40.3%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
479,194
% of Holdings
20.9%
Aurinia Pharmaceuticals Inc. (AUPH)
Robertson Stephen P. — Chief Legal Officer
Shares
20,975
Price
$16.97
Total Value
$355.95K
Shares Held After
600,787
% of Holdings
3.4%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,002
Price
$3.86
Total Value
$7.72K
Shares Held After
349,660
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,652
Price
$3.86
Total Value
$10.23K
Shares Held After
351,662
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
3,104
Price
$3.86
Total Value
$11.97K
Shares Held After
354,314
% of Holdings
0.9%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
13,160
Price
$3.86
Total Value
$50.76K
Shares Held After
245,930
% of Holdings
5.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
1,976
Price
$3.86
Total Value
$7.62K
Shares Held After
259,090
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
1,734
Price
$3.86
Total Value
$6.69K
Shares Held After
367,456
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
2,430
Price
$3.86
Total Value
$9.37K
Shares Held After
369,190
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
3,089
Price
$3.86
Total Value
$11.91K
Shares Held After
371,620
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
3,486
Price
$3.86
Total Value
$13.45K
Shares Held After
374,709
% of Holdings
0.9%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,558
Price
$3.86
Total Value
$6.01K
Shares Held After
227,520
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,575
Price
$3.86
Total Value
$9.93K
Shares Held After
409,410
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,389
Price
$3.86
Total Value
$13.07K
Shares Held After
411,985
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,598
Price
$3.86
Total Value
$10.02K
Shares Held After
415,374
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,469
Price
$3.86
Total Value
$9.52K
Shares Held After
317,095
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
17,281
Price
$3.86
Total Value
$66.65K
Shares Held After
319,564
% of Holdings
5.1%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,110
Price
$3.86
Total Value
$4.28K
Shares Held After
145,854
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,872
Price
$3.86
Total Value
$11.08K
Shares Held After
146,964
% of Holdings
1.9%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
19,178
Price
$3.86
Total Value
$73.97K
Shares Held After
1,619,792
% of Holdings
1.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
8,411
Price
$3.86
Total Value
$32.44K
Shares Held After
1,638,970
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,976
Price
$3.86
Total Value
$61.62K
Shares Held After
1,647,381
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,009
Price
$3.86
Total Value
$57.89K
Shares Held After
1,663,357
% of Holdings
0.9%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$18.95
Total Value
$189.50K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,437
Price
$25.98
Total Value
$193.19K
Shares Held After
38,400
% of Holdings
16.2%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
34,658
Price
$7.50
Total Value
$259.94K
Shares Held After
465,012
% of Holdings
6.9%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
29,697
Price
$2.12
Total Value
$62.96K
Shares Held After
488,267
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
41,832
Price
$69.09
Total Value
$2.89M
Shares Held After
174,606
% of Holdings
19.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
31,799
Price
$69.09
Total Value
$2.20M
Shares Held After
216,438
% of Holdings
12.8%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,457
Price
$15.54
Total Value
$22.64K
Shares Held After
16,220
% of Holdings
8.2%
Showing 801–850 of 3159 transactions (page 17 of 64)